Where authors are identified as personnel of the International Agency for Research on Cancer/World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer/World Health Organization.
Trending
- How Are Key Lymphoma Data From ASCO and EHA 2026 Shaping Treatment?
- Introduction and Treatment Landscape Overview
- Closely watched Pfizer lung cancer drug falls short in clinical trial
- Long-term health risks of e-cigarettes after smoking cessation
- TROPION-Breast01 and Comparative ADC Data
- FDA Approves Afami-cel in Metastatic Synovial Sarcoma
- 52 “There’s No Place Like Home”: Best Practices Bringing Cutting-Edge Breast Cancer Treatments Closer to Home
- 51 Metastasis-Directed Therapy and Local-Regional Therapy for Patients With Metastatic Breast Cancer: Who, What, Where, and When?
Tuesday, June 23
